Arcellx (ACLX) EBIT (2021 - 2025)
Arcellx (ACLX) recorded quarterly EBIT of $237.5 million in Q4 2025, up 484.38% quarter-over-quarter from -$61.8 million in Q3 2025, and up 546.74% on a YoY basis from $36.7 million in Q4 2024.
Arcellx (ACLX) EBIT (2021 - 2025) Analysis & Trends
Arcellx's EBIT history runs 5 years deep, the most recent figure standing at $237.5 million for Q4 2025.
- In Q4 2025, EBIT rose 546.74% year-over-year to $237.5 million; the TTM figure through Dec 2025 stood at $48.1 million (up 134.93% YoY), while the FY2025 annual figure was $48.1 million, up 134.93% from the prior year.
- EBIT was $237.5 million for Q4 2025 at Arcellx, up from -$61.8 million in the prior quarter.
- In the past five years, EBIT ranged from a high of $237.5 million in Q4 2025 to a low of -$93.9 million in Q3 2022.
- Historically, EBIT has averaged -$21.8 million across 5 years, with a median of -$30.9 million in 2022.
- The sharpest annual moves came in 2024 and 2025: EBIT sank 454.37% in 2024, then surged 546.74% in 2025.
- A 5-year view of EBIT shows it stood at -$20.7 million in 2021, then sank by 93.27% to -$40.0 million in 2022, then surged by 137.49% to $15.0 million in 2023, then tumbled by 454.37% to -$53.2 million in 2024, then soared by 546.74% to $237.5 million in 2025.
- The last three EBIT figures came in at $237.5 million (Q4 2025), -$61.8 million (Q3 2025), and -$58.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 237.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 237.45 Mn |
| Sep 30, 2025 | -61.78 Mn |
| Jun 30, 2025 | -58.73 Mn |
| Mar 31, 2025 | -68.90 Mn |
| Dec 31, 2024 | -53.15 Mn |
| Sep 30, 2024 | -33.62 Mn |
| Jun 30, 2024 | -34.99 Mn |
| Mar 31, 2024 | -15.81 Mn |
| Dec 31, 2023 | 15.00 Mn |
| Sep 30, 2023 | -44.86 Mn |
| Jun 30, 2023 | -29.56 Mn |
| Mar 31, 2023 | -30.46 Mn |
| Dec 31, 2022 | -40.00 Mn |
| Sep 30, 2022 | -93.88 Mn |
| Jun 30, 2022 | -31.29 Mn |
| Mar 31, 2022 | -26.09 Mn |
| Dec 31, 2021 | -20.70 Mn |
| Sep 30, 2021 | -17.11 Mn |
| Jun 30, 2021 | -15.93 Mn |
| Mar 31, 2021 | -11.28 Mn |